Asker Healthcare
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equip… Read more
Asker Healthcare (ASKER) - Total Liabilities
Latest total liabilities as of September 2025: Skr9.43 Billion SEK
Based on the latest financial reports, Asker Healthcare (ASKER) has total liabilities worth Skr9.43 Billion SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Asker Healthcare - Total Liabilities Trend (2021–2024)
This chart illustrates how Asker Healthcare's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Asker Healthcare Competitors by Total Liabilities
The table below lists competitors of Asker Healthcare ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fujian Aonong Biological Technology Group Incorporation Ltd
SHG:603363
|
China | CN¥5.36 Billion |
|
Kingclean Electric Co Ltd
SHG:603355
|
China | CN¥9.67 Billion |
|
Kinnevik AB Series A
LSE:0RGZ
|
UK | Skr2.25 Billion |
|
Leggett & Platt Incorporated
NYSE:LEG
|
USA | $2.51 Billion |
|
Aperam SA
OTCGREY:APMSF
|
USA | $1.97 Billion |
|
Embracer Group AB
PINK:THQQF
|
USA | $8.73 Billion |
|
Dalian Zeus Entertainment
SHE:002354
|
China | CN¥648.57 Million |
|
Apeloa Pharmaceutical Co Ltd
SHE:000739
|
China | CN¥5.61 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Asker Healthcare's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Asker Healthcare's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Asker Healthcare (2021–2024)
The table below shows the annual total liabilities of Asker Healthcare from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr9.62 Billion | +16.07% |
| 2023-12-31 | Skr8.29 Billion | +11.31% |
| 2022-12-31 | Skr7.44 Billion | +34.33% |
| 2021-12-31 | Skr5.54 Billion | -- |